Article
Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability.
Scientific reports - 10 Oct 2016
Magrì Andrea, Belfiore Ramona, Reina Simona, Tomasello Marianna Flora, Di Rosa Maria Carmela, Guarino Francesca, Leggio Loredana, De Pinto Vito, Messina Angela
Abstract excerpt
Superoxide Dismutase 1 mutants associate with 20-25% of familial Amyotrophic Lateral Sclerosis (ALS) cases, producing toxic aggregates on mitochondria, notably in spinal cord. The Voltage Dependent Anion Channel isoform 1 (VDAC1) in the outer mitochondrial membrane is a docking site for SOD1 G93A mutant in ALS mice and the physiological receptor of Hexokinase I (HK1), which is poorly expressed in mouse spinal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
